Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CERo Therapeutics Holdings ( (CERO) ) has provided an announcement.
On April 27, 2026, CERo Therapeutics Holdings issued and sold a $500,000 principal convertible promissory note to Keystone Capital Partners for a purchase price of $400,000, with the facility allowing total borrowings of up to $1 million and bearing 10% annual interest until maturity on April 27, 2027. The note is convertible into common stock at the lesser of $0.05 per share or 80% of the average of the five lowest intraday trading prices over the prior 20 days, subject to a 4.99% ownership cap, and the company has committed to register the resale of the underlying shares, signaling further potential equity issuance and dilution for existing shareholders.
The transaction was executed as a private offering exempt from registration under U.S. securities laws, relying on provisions for non-public offerings to an accredited investor and investor representations about investment intent and sophistication. Any future shares issued upon conversion of the note will likewise rely on registration exemptions, underscoring CERo Therapeutics’ use of private, discounted convertible financing to access capital markets while managing regulatory burdens and ownership concentration limits.
The most recent analyst rating on (CERO) stock is a Hold with a $0.10 price target. To see the full list of analyst forecasts on CERo Therapeutics Holdings stock, see the CERO Stock Forecast page.
More about CERo Therapeutics Holdings
CERo Therapeutics Holdings, Inc. is a Delaware-incorporated company whose common stock is publicly traded in the U.S. capital markets. The company raises capital through securities offerings, including convertible promissory notes that can be exchanged into its common stock, reflecting an ongoing reliance on structured financing arrangements to support its operations and growth plans.
Average Trading Volume: 519,955
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.16M
See more insights into CERO stock on TipRanks’ Stock Analysis page.